NYSE:BSX

Boston Scientific Stock News

etoro logo Buy BSX
*Your capital is at risk
$47.69
+0.0100 (+0.0210%)
At Close: Jun 03, 2026
Expand NYSE: BSX Boston Scientific Today's Change (-17.50%) $-16.03 Current Price $75.59 Key Data Points Market Cap $136B Day's Range $75.00 - $81.68 52wk Range $75.00 - $109.50 Volume 3.3M Avg Vol 10
Boston Scientific Corporation (BSX) Q4 2025 Earnings Call Transcript
Total Revenue: $20.74 billion for full year 2025, 19.9% reported growth versus 2024.Q4 Revenue: $5.286 billion, 15.9% reported growth versus Q4 2024.Organic Re
BSX beats Q4 EPS and revenue estimates and lifts margins, but shares slide 9.1% in pre-market as investors weigh outlook and guidance.

Why Boston Scientific Stock Plummeted Today

01:01pm, Wednesday, 04'th Feb 2026
Boston Scientific grew sales and adjusted earnings per share by 16% and 14% in the fourth quarter. However, the company's guidance underwhelmed the market.
While the top- and bottom-line numbers for Boston Scientific (BSX) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metri
Stock futures pointed to a mixed open Wednesday, a day after major indexes sank as technology shares sold off. Meanwhile, gold and silver futures continued to rebound after retreating from recent high
Sales rose 16%, but the medical-device maker issued a soft forecast for the year, sending shares down premarket.
Boston Scientific (BSX) came out with quarterly earnings of $0.8 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.7 per share a year ago.
Boston Scientific stock tumbled early Wednesday after its fourth-quarter electrophysiology sales came in light.
The medical-device maker beats quarterly earnings expectations but offers a disappointing outlook for the current quarter.
Boston Scientific Corp forecast modest 2026 revenue growth and profit just below Wall Street expectations on Wednesday, overshadowing a strong fourth-quarter performance and sending its shares down mo
MARLBOROUGH, Mass., Feb. 4, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.286 billion during the fourth quarter of 2025, growing 15.9 percent on a reported
Boston Scientific Corporation (NYSE: BSX) will release earnings for its fourth quarter before the opening bell on Wednesday, Feb. 4.
Guru Stock PicksT Rowe Price Equity Income Fund has made the following transactions:Reduce in MET by 1.04%Sold out in ADBEAdd in REXR by 1.73%New position in CO
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE